A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) became a global human health threat since its first documentation in humans in 2012. An efficient vaccine for the prophylaxis of humans in hotspots of the infection (e.g., Saudi Arabia) is necessary but no commercial vaccines are yet approved....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pathogens
Autors principals: Shehata, Mahmoud M., Kandeil, Ahmed, Mostafa, Ahmed, Mahmoud, Sara H., Gomaa, Mokhtar R., El-Shesheny, Rabeh, Webby, Richard, Kayali, Ghazi, A. Ali, Mohamed
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963271/
https://ncbi.nlm.nih.gov/pubmed/31810359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens8040281
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars